ALEXIS LEVITAS: Open Payments
NPI 1205485109 · BUFFALO GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 76 payments from 15 companies in 2025. Trend: 2023 $2,422 · 2024 $2,057 · 2025 $1,726
Food & beverage: $1,438Education: $289
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $284 |
| ABBVIE INC. | 14 | $241 |
| Regeneron Healthcare Solutions, Inc. | 5 | $188 |
| GENZYME CORPORATION | 9 | $184 |
| Novartis Pharmaceuticals Corporation | 8 | $169 |
| UCB, Inc. | 5 | $150 |
| Sun Pharmaceutical Industries Inc. | 2 | $113 |
| PFIZER INC. | 5 | $107 |
| Incyte Corporation | 3 | $71 |
| Lilly USA, LLC | 3 | $67 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, CIBINQO, OPZELURA, RINVOQ.
Industry payments across IL — which companies pay providers there.
